Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effect of zinc sulfate in improving the symptoms of schizophrenia patients
IRCT20200815048417N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in schizophrenia, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
zinc
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20200815048417N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200815048417N1.